Skip to content
  • Friday, 14 August 2026
  • 11:52 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Potential Anticancer Effects of GLP-1 Receptor Agonists: A Promising Frontier, Yet Still Under Intense Scientific Scrutiny
Environmental & Analytical Chemistry

The Potential Anticancer Effects of GLP-1 Receptor Agonists: A Promising Frontier, Yet Still Under Intense Scientific Scrutiny

Abdurrohim Arsyad May 12, 2026 0

SAN DIEGO – The rapidly expanding therapeutic landscape of glucagon-like peptide-1 (GLP-1) receptor agonists, widely recognized for their transformative impact…

Read More
Environmental & Analytical Chemistry

GLP-1 Receptor Agonists and the Emerging Question of Anticancer Effects

Abdurrohim Arsyad May 5, 2026 0

The rapidly expanding landscape of drugs designed to mimic glucagon-like peptide-1 (GLP-1), famously exemplified by Ozempic and Wegovy, is increasingly…

Read More
Inflammation turns bone marrow into a breeding ground for diseaseScientists Identify Karyoptosis as a Key Mechanism of Neurodegeneration in Alzheimer’s Disease and Frontotemporal DementiaSmall study suggests probiotic yogurt strain may boost immunotherapy response in lung cancerThe Galactic Center Excess and the Mystery of Two-Component Dark Matter: New Research Explains the Silence of Dwarf Galaxies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ